Company: IPODW
Filing Date: 2025-04-29
Form Type: S-1/A
Source: 0001213900-25-036656
Chunk: 171

Company: Dune Acquisition Corp II
Filing Date: 2025-04-29
Form: S-1/A
Chunk 171
---
 at any time (based on our management team’s ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing demand deposit account at a bank. Due to the short -termnature of these investments, we believe there will be no associated material exposure to interest rate risk. 112 Related Party Transactions On September 27, 2024, our sponsor paid $25,000, or approximately $0.004 per share, to cover certain of our offering costs in exchange for 6,900,000 founder shares. On April 22, 2025 , the number of outstanding founder shares was reduced to 5,750,000. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 14,375,000 units if the underwriters’ over -allotment option is exercised in full, and therefore that such founder shares would represent approximately 28.4 % of the outstanding shares after this offering. Up to 750,000 of the founder shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotment is exercised. If we increase or decrease the size of the offering, we will effect a share capitalization or a share repurchase or redemption or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of this offering in such amount as to maintain the number of founder shares, on an as -converted basis, at approximately 28.4 % of our issued and outstanding ordinary shares upon the consummation of this offering. Our sponsor has committed to purchase an aggregate of 1,880,000 private placement warrants (or 2,000,000 warrants if the underwriters’ over -allotment option is exercised in full), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $1,880,000 (or $2,000,000 in the aggregate if the underwriters’ over -allotment option is exercised in full), in a private placement that will close simultaneously with the closing of this offering. If we do not complete an initial business combination within the completion window, the private placement warrants will be worthless. The private placement warrants will be identical to the warrants